-report

Global Irritable Bowel Syndrome (IBS) Market Size, Status and Forecast 2020-2026

  • Esherpa Code:
  • ES-394983
  • Published On:
  • 20-Mar-20
  • Pages:
  • 97
  • Publisher Id:
  • 7087

Downloads Details

Single User $ 3900
Enterprise License $ 7800

Key Questions Answered

Market Size

Size of the market ?
Market size in the coming five years ?

Geolocation

Biggest contributor to this market ?
Countries to watch.

Key Vendors

Vendors in the market
Growth stratagies they've adpated?

Opportunities

Factors contributing growth of the market ?
Prominent opportunities in the market?

CAGR

Growth forcast foe the next 5 years ?
Fastest-growing segments ?

Challenges

Challenges in the present scenario ?
Factors Impacting market growth

                                                  
This report focuses on the global Irritable Bowel Syndrome (IBS) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Irritable Bowel Syndrome (IBS) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study Allergan Bausch Health Takeda Sucampo Pharmaceuticals McNeil Consumer Healthcare Sebela Pharmaceuticals Astellas Pharmaceuticals IM HealthScience Market segment by Type, the product can be split into IBS-D Drug IBS-C Drug Other Market segment by Application, split into Women Men Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Irritable Bowel Syndrome (IBS) status, future forecast, growth opportunity, key market and key players. To present the Irritable Bowel Syndrome (IBS) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by type, market and key regions. In this study, the years considered to estimate the market size of Irritable Bowel Syndrome (IBS) are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
                                                
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Irritable Bowel Syndrome (IBS) Revenue 1.4 Market Analysis by Type 1.4.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 IBS-D Drug 1.4.3 IBS-C Drug 1.4.4 Other 1.5 Market by Application 1.5.1 Global Irritable Bowel Syndrome (IBS) Market Share by Application: 2020 VS 2026 1.5.2 Women 1.5.3 Men 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Irritable Bowel Syndrome (IBS) Market Perspective (2015-2026) 2.2 Irritable Bowel Syndrome (IBS) Growth Trends by Regions 2.2.1 Irritable Bowel Syndrome (IBS) Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Irritable Bowel Syndrome (IBS) Historic Market Share by Regions (2015-2020) 2.2.3 Irritable Bowel Syndrome (IBS) Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Irritable Bowel Syndrome (IBS) Market Growth Strategy 2.3.6 Primary Interviews with Key Irritable Bowel Syndrome (IBS) Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Irritable Bowel Syndrome (IBS) Players by Market Size 3.1.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue (2015-2020) 3.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2015-2020) 3.1.3 Global Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio 3.2.1 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome (IBS) Revenue in 2019 3.3 Irritable Bowel Syndrome (IBS) Key Players Head office and Area Served 3.4 Key Players Irritable Bowel Syndrome (IBS) Product Solution and Service 3.5 Date of Enter into Irritable Bowel Syndrome (IBS) Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Type (2015-2020) 4.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2021-2026) 5 Irritable Bowel Syndrome (IBS) Breakdown Data by Application (2015-2026) 5.1 Global Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) 5.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Irritable Bowel Syndrome (IBS) Market Size (2015-2020) 6.2 Irritable Bowel Syndrome (IBS) Key Players in North America (2019-2020) 6.3 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) 6.4 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) 7 Europe 7.1 Europe Irritable Bowel Syndrome (IBS) Market Size (2015-2020) 7.2 Irritable Bowel Syndrome (IBS) Key Players in Europe (2019-2020) 7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) 7.4 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) 8 China 8.1 China Irritable Bowel Syndrome (IBS) Market Size (2015-2020) 8.2 Irritable Bowel Syndrome (IBS) Key Players in China (2019-2020) 8.3 China Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) 8.4 China Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) 9 Japan 9.1 Japan Irritable Bowel Syndrome (IBS) Market Size (2015-2020) 9.2 Irritable Bowel Syndrome (IBS) Key Players in Japan (2019-2020) 9.3 Japan Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) 9.4 Japan Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Irritable Bowel Syndrome (IBS) Market Size (2015-2020) 10.2 Irritable Bowel Syndrome (IBS) Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) 10.4 Southeast Asia Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) 11 India 11.1 India Irritable Bowel Syndrome (IBS) Market Size (2015-2020) 11.2 Irritable Bowel Syndrome (IBS) Key Players in India (2019-2020) 11.3 India Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) 11.4 India Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Irritable Bowel Syndrome (IBS) Market Size (2015-2020) 12.2 Irritable Bowel Syndrome (IBS) Key Players in Central & South America (2019-2020) 12.3 Central & South America Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) 12.4 Central & South America Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Allergan 13.1.1 Allergan Company Details 13.1.2 Allergan Business Overview and Its Total Revenue 13.1.3 Allergan Irritable Bowel Syndrome (IBS) Introduction 13.1.4 Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020)) 13.1.5 Allergan Recent Development 13.2 Bausch Health 13.2.1 Bausch Health Company Details 13.2.2 Bausch Health Business Overview and Its Total Revenue 13.2.3 Bausch Health Irritable Bowel Syndrome (IBS) Introduction 13.2.4 Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) 13.2.5 Bausch Health Recent Development 13.3 Takeda 13.3.1 Takeda Company Details 13.3.2 Takeda Business Overview and Its Total Revenue 13.3.3 Takeda Irritable Bowel Syndrome (IBS) Introduction 13.3.4 Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) 13.3.5 Takeda Recent Development 13.4 Sucampo Pharmaceuticals 13.4.1 Sucampo Pharmaceuticals Company Details 13.4.2 Sucampo Pharmaceuticals Business Overview and Its Total Revenue 13.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction 13.4.4 Sucampo Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) 13.4.5 Sucampo Pharmaceuticals Recent Development 13.5 McNeil Consumer Healthcare 13.5.1 McNeil Consumer Healthcare Company Details 13.5.2 McNeil Consumer Healthcare Business Overview and Its Total Revenue 13.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Introduction 13.5.4 McNeil Consumer Healthcare Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) 13.5.5 McNeil Consumer Healthcare Recent Development 13.6 Sebela Pharmaceuticals 13.6.1 Sebela Pharmaceuticals Company Details 13.6.2 Sebela Pharmaceuticals Business Overview and Its Total Revenue 13.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction 13.6.4 Sebela Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) 13.6.5 Sebela Pharmaceuticals Recent Development 13.7 Astellas Pharmaceuticals 13.7.1 Astellas Pharmaceuticals Company Details 13.7.2 Astellas Pharmaceuticals Business Overview and Its Total Revenue 13.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction 13.7.4 Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) 13.7.5 Astellas Pharmaceuticals Recent Development 13.8 IM HealthScience 13.8.1 IM HealthScience Company Details 13.8.2 IM HealthScience Business Overview and Its Total Revenue 13.8.3 IM HealthScience Irritable Bowel Syndrome (IBS) Introduction 13.8.4 IM HealthScience Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) 13.8.5 IM HealthScience Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details
                                                  
List of Tables Table 1. Irritable Bowel Syndrome (IBS) Key Market Segments Table 2. Key Players Covered: Ranking by Irritable Bowel Syndrome (IBS) Revenue Table 3. Ranking of Global Top Irritable Bowel Syndrome (IBS) Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of IBS-D Drug Table 6. Key Players of IBS-C Drug Table 7. Key Players of Other Table 8. Global Irritable Bowel Syndrome (IBS) Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Irritable Bowel Syndrome (IBS) Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Irritable Bowel Syndrome (IBS) Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Irritable Bowel Syndrome (IBS) Market Share by Regions (2015-2020) Table 12. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Irritable Bowel Syndrome (IBS) Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Irritable Bowel Syndrome (IBS) Market Growth Strategy Table 18. Main Points Interviewed from Key Irritable Bowel Syndrome (IBS) Players Table 19. Global Irritable Bowel Syndrome (IBS) Revenue by Players (2015-2020) (Million US$) Table 20. Global Irritable Bowel Syndrome (IBS) Market Share by Players (2015-2020) Table 21. Global Top Irritable Bowel Syndrome (IBS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2019) Table 22. Global Irritable Bowel Syndrome (IBS) by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Irritable Bowel Syndrome (IBS) Product Solution and Service Table 25. Date of Enter into Irritable Bowel Syndrome (IBS) Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) (Million US$) Table 28. Global Irritable Bowel Syndrome (IBS) Market Size Share by Type (2015-2020) Table 29. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2021-2026) Table 30. Global Irritable Bowel Syndrome (IBS) Market Size Share by Application (2015-2020) Table 31. Global Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) (Million US$) Table 32. Global Irritable Bowel Syndrome (IBS) Market Size Share by Application (2021-2026) Table 33. North America Key Players Irritable Bowel Syndrome (IBS) Revenue (2019-2020) (Million US$) Table 34. North America Key Players Irritable Bowel Syndrome (IBS) Market Share (2019-2020) Table 35. North America Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) (Million US$) Table 36. North America Irritable Bowel Syndrome (IBS) Market Share by Type (2015-2020) Table 37. North America Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) (Million US$) Table 38. North America Irritable Bowel Syndrome (IBS) Market Share by Application (2015-2020) Table 39. Europe Key Players Irritable Bowel Syndrome (IBS) Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Irritable Bowel Syndrome (IBS) Market Share (2019-2020) Table 41. Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) (Million US$) Table 42. Europe Irritable Bowel Syndrome (IBS) Market Share by Type (2015-2020) Table 43. Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) (Million US$) Table 44. Europe Irritable Bowel Syndrome (IBS) Market Share by Application (2015-2020) Table 45. China Key Players Irritable Bowel Syndrome (IBS) Revenue (2019-2020) (Million US$) Table 46. China Key Players Irritable Bowel Syndrome (IBS) Market Share (2019-2020) Table 47. China Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) (Million US$) Table 48. China Irritable Bowel Syndrome (IBS) Market Share by Type (2015-2020) Table 49. China Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) (Million US$) Table 50. China Irritable Bowel Syndrome (IBS) Market Share by Application (2015-2020) Table 51. Japan Key Players Irritable Bowel Syndrome (IBS) Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Irritable Bowel Syndrome (IBS) Market Share (2019-2020) Table 53. Japan Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) (Million US$) Table 54. Japan Irritable Bowel Syndrome (IBS) Market Share by Type (2015-2020) Table 55. Japan Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) (Million US$) Table 56. Japan Irritable Bowel Syndrome (IBS) Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Irritable Bowel Syndrome (IBS) Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Irritable Bowel Syndrome (IBS) Market Share (2019-2020) Table 59. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Irritable Bowel Syndrome (IBS) Market Share by Type (2015-2020) Table 61. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Irritable Bowel Syndrome (IBS) Market Share by Application (2015-2020) Table 63. India Key Players Irritable Bowel Syndrome (IBS) Revenue (2019-2020) (Million US$) Table 64. India Key Players Irritable Bowel Syndrome (IBS) Market Share (2019-2020) Table 65. India Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) (Million US$) Table 66. India Irritable Bowel Syndrome (IBS) Market Share by Type (2015-2020) Table 67. India Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) (Million US$) Table 68. India Irritable Bowel Syndrome (IBS) Market Share by Application (2015-2020) Table 69. Central & South America Key Players Irritable Bowel Syndrome (IBS) Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Irritable Bowel Syndrome (IBS) Market Share (2019-2020) Table 71. Central & South America Irritable Bowel Syndrome (IBS) Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Irritable Bowel Syndrome (IBS) Market Share by Type (2015-2020) Table 73. Central & South America Irritable Bowel Syndrome (IBS) Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Irritable Bowel Syndrome (IBS) Market Share by Application (2015-2020) Table 75. Allergan Company Details Table 76. Allergan Business Overview Table 77. Allergan Product Table 78. Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) (Million US$) Table 79. Allergan Recent Development Table 80. Bausch Health Company Details Table 81. Bausch Health Business Overview Table 82. Bausch Health Product Table 83. Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) (Million US$) Table 84. Bausch Health Recent Development Table 85. Takeda Company Details Table 86. Takeda Business Overview Table 87. Takeda Product Table 88. Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) (Million US$) Table 89. Takeda Recent Development Table 90. Sucampo Pharmaceuticals Company Details Table 91. Sucampo Pharmaceuticals Business Overview Table 92. Sucampo Pharmaceuticals Product Table 93. Sucampo Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) (Million US$) Table 94. Sucampo Pharmaceuticals Recent Development Table 95. McNeil Consumer Healthcare Company Details Table 96. McNeil Consumer Healthcare Business Overview Table 97. McNeil Consumer Healthcare Product Table 98. McNeil Consumer Healthcare Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) (Million US$) Table 99. McNeil Consumer Healthcare Recent Development Table 100. Sebela Pharmaceuticals Company Details Table 101. Sebela Pharmaceuticals Business Overview Table 102. Sebela Pharmaceuticals Product Table 103. Sebela Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) (Million US$) Table 104. Sebela Pharmaceuticals Recent Development Table 105. Astellas Pharmaceuticals Company Details Table 106. Astellas Pharmaceuticals Business Overview Table 107. Astellas Pharmaceuticals Product Table 108. Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) (Million US$) Table 109. Astellas Pharmaceuticals Recent Development Table 110. IM HealthScience Business Overview Table 111. IM HealthScience Product Table 112. IM HealthScience Company Details Table 113. IM HealthScience Revenue in Irritable Bowel Syndrome (IBS) Business (2015-2020) (Million US$) Table 114. IM HealthScience Recent Development Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Global Irritable Bowel Syndrome (IBS) Market Share by Type: 2020 VS 2026 Figure 2. IBS-D Drug Features Figure 3. IBS-C Drug Features Figure 4. Other Features Figure 5. Global Irritable Bowel Syndrome (IBS) Market Share by Application: 2020 VS 2026 Figure 6. Women Case Studies Figure 7. Men Case Studies Figure 8. Irritable Bowel Syndrome (IBS) Report Years Considered Figure 9. Global Irritable Bowel Syndrome (IBS) Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Irritable Bowel Syndrome (IBS) Market Share by Regions: 2020 VS 2026 Figure 11. Global Irritable Bowel Syndrome (IBS) Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Irritable Bowel Syndrome (IBS) Market Share by Players in 2019 Figure 14. Global Top Irritable Bowel Syndrome (IBS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome (IBS) Revenue in 2019 Figure 16. North America Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Allergan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Allergan Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2015-2020) Figure 25. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2015-2020) Figure 27. Takeda Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Takeda Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2015-2020) Figure 29. Sucampo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Sucampo Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2015-2020) Figure 31. McNeil Consumer Healthcare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. McNeil Consumer Healthcare Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2015-2020) Figure 33. Sebela Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Sebela Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2015-2020) Figure 35. Astellas Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Astellas Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2015-2020) Figure 37. IM HealthScience Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. IM HealthScience Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2015-2020) Figure 39. Bottom-up and Top-down Approaches for This Report Figure 40. Data Triangulation Figure 41. Key Executives Interviewed

What Set Us Apart

Research Analyst
Support

Rest assured that with vetted publishers, you will get the best quality output

Best Buying
Experience

Rest assured that with vetted publishers, you will get the best quality output

Unmatched
Expertise

Rest assured that with vetted publishers, you will get the best quality output

Assured
Quality

Rest assured that with vetted publishers, you will get the best quality output

Widest Report
Option

Rest assured that with vetted publishers, you will get the best quality output

Customer
Centric

Rest assured that with vetted publishers, you will get the best quality output